Pediatric Brain Tumors Epidemiology

 

Key Highlights

 

• According to the study Johnson et al., there are >100 different histological subtypes of CNS tumors with the incidence of each varying by age and histologic subtype. Childhood CNS tumor incidence varies by country from 1.12–5.14 cases per 100,000 persons with the highest incidence in the United States.

 

• Pediatric Brain Tumors epidemiology is segmented as Total Pediatric Brain Tumors Incident Cases, Pediatric Brain Tumors Gender-specific Incident Cases, Pediatric Brain Tumors Diagnosed and Treatable Cases, and Pediatric Brain Tumors Type-specific Incident cases in the Pediatric Brain Tumor epidemiology report.

 

Request for Sample Report of  Pediatric Brain Tumors Epidemiology Report

 

DelveInsight's ‘Pediatric Brain Tumors Epidemiology Forecast — 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Pediatric Brain Tumors epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom,  and Japan, from 2021 to 2034.

 

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

 

Study Period: 2021-2034

 

Pediatric Brain Tumors Epidemiology: Disease Understanding

The DelveInsight’s Pediatric Brain Tumors epidemiology report gives a thorough understanding of Pediatric Brain Tumors by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. Pediatric central nervous system (CNS) tumors are the second most common childhood malignancy and the most common solid tumor in children. Little is known regarding the pathogenesis of most brain tumors in children. There are genetic syndromes that can predispose patients to getting brain tumors, such as neurofibromatosis type 1 (NF-1), tuberous sclerosis, Li-Fraumeni syndrome, and other less common inherited conditions, such as Gorlin syndrome or Turcot syndrome. 

Symptoms of Pediatric brain tumors vary depending on size and location of tumor and can occur a bit differently in each child. Growing tumors may cause increased pressure on the brain in the limited space in the skull. This is called increased intracranial pressure or ICP. This is not usually the case in babies, since their skull bones have not fully grown together. The most common symptoms include, headache, nausea, and seizures.

 

Pediatric Brain Tumors Diagnosis

The first and foremost step in evaluating Pediatric brain tumors is obtaining a comprehensive medical history and physical examination of the child. Examination procedures for a brain tumor may include neurological exam, CT, PET or MRI scan, X-ray, angiogram, myelogram and lumbar puncture.

 

Pediatric Brain Tumors Epidemiology

The Pediatric Brain Tumors epidemiology section provides insights about historical and current Pediatric brain tumors patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Key Findings

 

• According to the study Johnson et al., there are >100 different histological subtypes of CNS tumors with the incidence of each varying by age and histologic subtype. Childhood CNS tumor incidence varies by country from 1.12–5.14 cases per 100,000 persons with the highest incidence in the United States.

 

• The disease epidemiology covered in the report provides historical as well as forecasted Pediatric Brain Tumors epidemiology [segmented as Total Incident Cases of Pediatric Brain Tumors, Gender-specific Incident Cases of Pediatric Brain Tumors, Diagnosed and Treatable Cases of Pediatric Brain Tumors, and Type-specific Incident cases of Pediatric Brain Tumors] in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2021 to 2034.

 

Country Wise- Pediatric Brain Tumors Epidemiology

This section provides glimpse of the Pediatric Brain Tumors epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 

KOL- Views

To keep up with the current Pediatric Brain Tumors patient pool and forecasted trend, we take KOLs and SMEs ' opinions working in the Pediatric Brain Tumors domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate the patient pool and forecasted trend.

 

Learn how the therapeutic market will evolve and grow in the coming years: Pediatric Brain Tumors Market
 

Scope of the Pediatric Brain Tumors Epidemiology Report

• The report covers the descriptive overview of Pediatric Brain Tumors, explaining their causes, symptoms, pathophysiology, and genetic basis
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan
• The report assesses the disease risk and burden and highlights the unmet needs of Pediatric Brain Tumors
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population
• The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Pediatric Brain Tumors, Gender-specific Incident Cases of Pediatric Brain Tumors, Diagnosed and Treatable Cases of Pediatric Brain Tumors, and Type-specific Incident cases of Pediatric Brain Tumors

 

Pediatric Brain Tumors Epidemiology Report Highlights

• The companies and academics are working to assess challenges and seek opportunities that could influence Pediatric Brain Tumors R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Pediatric Brain Tumors 
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

 

Pediatric Brain Tumors Report Insights

• Patient Population
• Therapeutic Approaches

 

Pediatric Brain Tumors Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Pediatric brain tumors Epidemiology Segmentation

 

Pediatric Brain Tumors Report Assessment

• Disease Understanding
• Current Diagosis Practices and Guidelines
• Epidemiology Trends

 

Key Questions

 

Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of Pediatric brain tumors?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan?
• What is the historical Pediatric brain tumors patient pool in seven major markets covering the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan?
• What would be the forecasted patient pool of Pediatric brain tumors in seven major markets covering the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan?
• Where will be the growth opportunities in the 7MM concerning the patient population about Pediatric brain tumors?
• Out of all 7MM countries, which country would have the highest incident population of Pediatric brain tumors during the forecast period (2025-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2025-2034)?

 

 

Reasons to buy

• The report will help in developing business strategies by understanding trends shaping and driving the Pediatric brain tumors Disease market
• To understand the future market competition in the Pediatric brain tumors Disease market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Pediatric brain tumors Disease in the US, Europe (Germany, France, Italy, and Spain) and the UK, and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for the Pediatric brain tumors Disease market
• To understand the future market competition in the Pediatric brain tumors Disease market